Ferric Ammonium Citrate Effervescent Granules
Ferric Ammonium Citrate Effervescent Granules was launched in 2004. It is an oral magnetic resonance contrast agent/media approved by NMPA in the market, which is a safe and effective double contrast media products with the advantages of convenient use and good safety. This ammonium iron citratecan significantly improve the images quality of MRCP and MRU, and can also be used as a positive contrast agent for the digestive tract.
Product name: Ferric Ammonium Citrate Effervescent Granules
Type: Oral MRIContrast Medium
Ingredients: Ferric ammonium citrate
Specification: 3g: 0.6g（Fe 129mg), 6g: 1.2g（Fe 258mg）
Posology and method of administration: Oral
Adverse reactions: Foreign clinical data reported that after using this MRI contrast medium, 0.1-0.5% of patients has diarrhea, 0.1% had nausea, vomiting, and decreased appetite, and a very small number of patients has stomach discomfort and bloating. All the above symptoms can be eliminated by themselves.
Shelf life: 24 months
Indications of Ferric Ammonium Citrate Effervescent Granules
Used for magnetic resonance abdominal imaging, angiography of the digestive tract (stomach duodenum and jejunum).
Precautions of Ferric Ammonium Citrate Effervescent Granules
Use with caution in the following patients: patients with the gastrointestinal tract such as peptic ulcer, ulcerative colitis, local enteritis, etc.
The stool appearing black after administration is a normal phenomenon.
During the ferric ammonium citrate uses, false-positive for occult blood may occur.
Founded in 1992, Beiluis mainly engaged in the research & development, production and sales of pharmaceutical products. It is high-tech innovation company with core competence in the Contrast Media domestic. It has around 650 employees with 0.82 Bn/￥ revenue in 2019. Beilu provides complete Contrast Media products suitable for X-Ray and Magnetic Resonance Imaging (MRI), and it is the leading manufacturer in the Contrast Media field in China. It is one of the 1st batches of listed enterprises in GEM of SZSE (Ticker: 300016.SZ) in China.
在线联系供应商
Other supplier products
 |
Gadobutrol Injection/API | In 2020, Beilu launched its macrocyclic Contrast Media- Gadobutrol Injection, it is gadolinium-based non-ionic Contrast Media, a paramagnetic Contr... |
 |
Glimepiride Tablets | Glimepiride 1 Tablet is a sulfonylurea hypoglycemic drug that can be used in combination with insulin. In 2001, glimepiride 2 tablet (Dibei), as th... |
 |
Calcobutrol | Calcobutrol CAS No.: Molecular formula: C18H32CaN4O9 Molecular weight: 488.5461 Quality standard: CP Characteristics: White or off-... |
 |
Anti-Diabetic Drugs | The number of people with diabetes rose from 151 million in 2000 to 463 million in 2019; by 2045 this number will rise to 700 million. 1 in 5 of th... |
 |
Ferric Ammonium Citrate Effervescent Granules | Ferric Ammonium Citrate Effervescent Granules was launched in 2004. It is an oral magnetic resonance contrast agent/media approved by NMPA in the m... |
Same products
 |
Custom Peptide Synthesis Services | 卖方: PeptiOrigin Biotechnology Co., Ltd. | Custom Peptide Synthesis Services Tailored Peptide Solutions for Research and Industry At... |
 |
Peptide Drug Delivery | 卖方: PeptiOrigin Biotechnology Co., Ltd. | Peptide Drug Delivery Precision Delivery for Enhanced Therapeutic and Cosmetic Applications ... |
|
|
Ferric Ammonium Citrate Effervescent Granules | 卖方: 北京北陆药业股份有限公司 | Ferric Ammonium Citrate Effervescent Granules was launched in 2004. It is an oral magnetic resona... |
 |
Calcobutrol | 卖方: 北京北陆药业股份有限公司 | Calcobutrol CAS No.: Molecular formula: C18H32CaN4O9 Molecular weight: 488.5461 Qualit... |
 |
Anti-Diabetic Drugs | 卖方: 北京北陆药业股份有限公司 | The number of people with diabetes rose from 151 million in 2000 to 463 million in 2019; by 2045 ... |
